Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: An evaluation by a randomized trial

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 2946-2951

  Bonnema, Steen Joop ^a   Bennedbæk, Finn Noe ^a   Veje, Annegrete ^a   Marving, Jens ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THIAMAZOLE; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; THYROID WEIGHT; THYROXINE BLOOD LEVEL; TOXIC GOITER; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33747664270     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0226     Document Type: Article

References (40)

1. Kalinyak JE, McDougall IR 2003 How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? J Clin Endocrinol Metab 88:975-977
2. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917
3. Abraham P, Avenell A, Park CM, Watson WA, Bevan JS 2005 A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol 153:489-498
4. Andrade VA, Gross JL, Maia AL 1999 Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. J Clin Endocrinol Metab 84:4012-4016
5. Burch HB, Solomon BL, Cooper DS, Ferguson P, Walpert N, Howard R 2001 The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after 131I ablation for Graves' disease. J Clin Endocrinol Metab 86:3016-3021
6. Alexander EK, Larsen PR 2002 High dose of 131I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 87:1073-1077
7. Velkeniers B, Cytryn R, Vanhaelst L, Jonckheer MH 1988 Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. Lancet 1:1127-1129
8. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA 2001 Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 86:3611-3617
9. Nygaard B, Hegedüs L, Ulriksen P, Nielsen KG, Hansen JM 1999 Radioiodine therapy for multinodular toxic goiter. Arch Intern Med 159:1364-1368
10. Körber C, Schneider P, Korber-Hafner N, Hanscheid H, Reiners C 2001 Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre? Eur J Nucl Med 28:1360-1364
11. Reynolds LR, Kotchen TA 1979 Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease. Arch Intern Med 139:651-653
12. Clerc J, Izembart M, Dagousset F, Jais JP, Heshmati HM, Chevalier A, Leger AF, Barritault L 1993 Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole. J Nucl Med 34:387-393
13. Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, Buell U 1999 Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 84:1229-1233
14. Marcocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A 1990 A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13:513-520
15. Andrade VA, Gross JL, Maia AL 2001 The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 86:3488-3493
16. Bonnema SJ, Bennedbæk FN, Gram J, Veje A, Marving J, Hegedüs L 2003 Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. Eur J Endocrinol 149:485-492
17. Braga M, Walpert N, Burch HB, Solomon BL, Cooper DS 2002 The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial. Thyroid 12:135-139
18. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR 1998 Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83:685-687
19. Tuttle RM, Patience T, Budd S 1995 Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5:243-247
20. Bonnema SJ, Bennedbæk FN, Veje A, Marving J, Hegedüs L 2004 Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab 89:4439-4444
21. Ahmad AM, Ahmad M, Young ET 2002 Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis. Eur J Endocrinol 146:767-775
22. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM 1983 The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260-263
23. Zanzonico PB, Becker DV, Hurley JR 2004 Enhancement of radioiodine treatment of small-pool hyperthyroidism with antithyroid drugs: kinetics and dosimetry. J Nucl Med 45:2102-2108
24. Moka D, Dietlein M, Schicha H 2002 Radioiodine therapy and thyrostatic drugs and iodine. Eur J Nucl Med Mol Imaging 29(Suppl 2):S486-S491
25. Kuenstner H, Dunkelmann A, Koch U, Groth P, Schuemichen C 2004 Recovery of radioiodine kinetics in the thyroid after discontinuation of thyrostasis. Eur J Nucl Med Mol Imaging 31(Suppl 2):S468
26. Traino AC, Di Martino F, Lazzeri M 2004 A dosimetric approach to patient-specific radioiodine treatment of Graves' disease with incorporation of treatment-induced changes in thyroid mass. Med Phys 31:2121-2127
27. Berg GE, Michanek AM, Holmberg EC, Fink M 1996 Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 37:228-232
28. Morris LF, Wilder MS, Waxman AD, Braunstein GD 2001 Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. Thyroid 11:749-755
29. Bogazzi F, Bartalena L, Brogioni S, Scarcello G, Burelli A, Campomori A, Manetti L, Rossi G, Pinchera A, Martino E 1999 Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab 84:499-503
30. Tepmongkol S 2002 Enhancement of radioiodine uptake in hyperthyroidism with hydrochlorothiazide: a prospective randomised control study. Eur J Nucl Med Mol Imaging 29:1307-1310
31. Di Martino F, Traino AC, Brill AB, Stabin MG, Lazzer M 2002 A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease. Phys Med Biol 47:1493-1499
32. Postgard P, Himmelman J, Lindencrona U, Bhogal N, Wiberg D, Berg G, Jansson S, Nystrom E, Forssell-Aronsson E, Nilsson M 2002 Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells. J Nucl Med 43:828-834
33. Catargi B, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A 1999 Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome. Eur J Endocrinol 141:117-121
34. Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Muller-Brand J, Muller B 2004 Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Eur J Clin Invest 34:365-370
35. Zantut-Wittmann DE, Ramos CD, Santos AO, Lima MM, Panzan AD, Facuri FV, Etchebehere EC, Lima MC, Tambascia MA, Camargo EE 2005 High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [131I]iodide therapy in Graves' disease. Nucl Med Commun 26:957-963
36. Wilson R, Chopra M, Bradley H, McKillop JH, Smith WE, Thomson JA 1989 Free radicals and Graves' disease: the effects of therapy. Clin Endocrinol (Oxf) 30:429-433
37. Isman CA, Yegen BC, Alican I 2003 Methimazole-induced hypothyroidism in rats ameliorates oxidative injury in experimental colitis. J Endocrinol 177:471-476
38. Imamura M, Aoki N, Saito T, Ohno Y, Maruyama Y, Yamaguchi J, Yamamoto T 1986 Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils. Acta Endocrinol (Copenh) 112:210-216
39. Wilson R, Buchanan L, Fraser WD, Jenkins C, Smith WE, Reglinski J, Thomson JA, McKillop JH 1998 Evidence for carbimazole as an antioxidant? Autoimmunity 27:149-153
40. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Chrousos GP, Koutras DA 2000 Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid 10:527-532